<DOC>
	<DOCNO>NCT00002162</DOCNO>
	<brief_summary>To evaluate antiviral activity safety two formulation saquinavir combination license nucleoside antiretroviral drug .</brief_summary>
	<brief_title>A Randomized , Parallel Arm , Comparative , Open Label , Multicenter Study Activity Safety Two Formulations Saquinavir Combination With Other Antiretroviral Drugs</brief_title>
	<detailed_description>Patients randomize receive either hard gel soft gel capsule saquinavir combination least one licensed nucleoside antiretroviral . Treatment continue 48 week . After first 16 week , patient give opportunity roll saquinavir formulation choice .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Zalcitabine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . Antiretroviral naiveness ( i.e. , less 4 week prior treatment ) least one license nucleoside drug . No 2 week prior treatment protease inhibitor . No active opportunistic infection serious AIDSdefining condition . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Malabsorption inadequate oral intake . Lab clinical abnormality bad grade 3 ( exerciseinduced CPK elevation ) . Unexplained , chronic diarrhea , define three loose stool per day persist 2 week within month prior study entry . Active malignancy anticipate need chemotherapy study . Anticipated need disallow medication study . Concurrent Medication : Excluded : Other protease inhibitor . Prior Medication : Excluded : More 4 week prior nucleoside antiretroviral select patient 's regimen . More 2 week protease inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1997</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Saquinavir</keyword>
</DOC>